Morgan Stanley analyst Hamza Fodderwala maintains NICE (NASDAQ:NICE) with a Overweight and lowers the price target from $290 to $240.
Morgan Stanley Maintains Overweight on NICE, Lowers Price Target to $240
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.